Not Verified

HSF DANBY RESEARCH GRANT PROGRAM

Hidradenitis Suppurativa Foundation

The Hidradenitis Suppurativa Foundation (HSF) is seeking grant applications that encourage research into the disease hidradenitis suppurativa (HS). The goal is the development of new clinical and translational lines of investigation in the field of HS that further patient care.

REVIEW CRITERIA

Reviewers will be asked to base their evaluations on the criteria listed below.

Relevance to hidradenitis suppurativa
Innovation
Strategy, methodology and analyses are well-reasoned and appropriate to accomplish the aims
Ability of investigator to accomplish aims
Potential problems, alternative strategies, and benchmarks for success are presented
Diversity of the research team and the patient cohort planned for study
Likelihood of leading to additional funding, and/or findings to directly impact patient care and/or raise disease awareness
Clinical trials are strongly discouraged as the level of funding for the Danby grant is likely inadequate to fund a robust clinical trial

REPORTING REQUIREMENTS

Within 60 days of completing the approved project, the grantee is required to submit a written report summarizing their research experience and findings. The grantee should also present the work at the annual scientific meeting of the HSF, the Symposium on Hidradenitis Suppurativa Advances (SHSA), or another national or international conference within two years of funding. The HS Foundation has allocated up to $1,500 per individual to support grantees in covering their travel expenses to the SHSA. Presenting at the SHSA does not preclude presenting at another national or international meeting, as the SHSA permits simultaneous submission of the same abstract to other meetings. If an approved project cannot be completed as originally proposed or within the time limits mandated, the grantee must immediately contact the HSF.

Upon Successful Application: Awardees will be asked to submit a headshot to be used to announce the successful applicants.

BUDGET: Each grant is up to $30,000 for one year. Indirect costs are not allowed. Provide a budget summary, including a concise statement of how you propose to allocate funds (amount and for what purpose). Award may be used to provide salary support for PI or other staff. List all personnel to be included in the project and their anticipated support. Travel and publication costs are not allowed.

AI Based Application Success Predictor

These rankings synthesize HSF's published review criteria for its Danby and Translational Research Grant Programs. They are not official numerical weights.

1

★★★★★

Direct relevance to hidradenitis suppurativa — Critical

The research must address HS specifically, its causes, disease activity, inflammation, complications, diagnosis, treatment or patient outcomes. General dermatology research without a clear HS connection is a weaker fit.

hs-foundation.org

2

★★★★★

Innovation and scientific novelty — Critical

Propose a new hypothesis, mechanism, biomarker, diagnostic approach or treatment strategy that could advance understanding or management of HS.

3

★★★★★

Potential to improve patient care — Critical

Explain how findings could improve disease control, reduce pain or tunnel formation, improve diagnosis, guide treatment decisions or address other important burdens experienced by people with HS.

4

★★★★★

Rigor of research strategy and analysis — Critical

Present clear aims, suitable methods, appropriate controls or comparison groups, meaningful endpoints and a defensible analysis plan. HSF explicitly identifies the quality of the strategy, methodology and analyses as a review criterion.

hs-foundation.org

5

★★★★☆

Feasibility and contingency planning — Very high

Demonstrate that the aims can be completed within the one-year project period. Identify potential problems, alternative strategies and objective benchmarks for success.

6

★★★★☆

Investigator capability and career-stage fit — Very high

Show that the principal investigator has the relevant skills, institutional support and responsibility to conduct the research. HSF encourages early-stage investigators, especially for its Danby and Translational Research programs.

hs-foundation.org

7

★★★★☆

Patient and caregiver involvement — Very high for translational awards

Incorporate input from people living with HS and/or caregivers into study conception, design and interpretation or completion. This is explicitly included in the Translational Research Grant review criteria.

hs-foundation.org

8

★★★★☆

Potential for future external funding — Very high

For translational awards, show how results could generate the preliminary data needed for larger NIH or other external funding. Outline the next grant or research stage that the award would enable.

hs-foundation.org

9

★★★☆☆

Diversity of the research team and patient cohort — High

Explain whether the study population adequately represents the intended HS population and whether the team has the complementary expertise needed to carry out the project. Both HSF grant programs list diversity among their review considerations.

hs-foundation.org

10

★★★★☆

Eligibility and application compliance — Essential gate

Confirm U.S.-based investigator eligibility for the Danby and Translational Research programs, institutional eligibility, the correct application format, direct-cost limits and deadline. Applications must also meet reporting and research-presentation requirements.

hs-foundation.org

Ranked summary table

Rank	Predictor	Importance
1	Direct HS relevance	Critical
2	Innovation	Critical
3	Patient-care impact	Critical
4	Methodological rigor	Critical
5	Feasibility and contingency planning	Very high
6	Investigator capability	Very high
7	Patient/caregiver input	Very high for Translational awards
8	Potential for future funding	Very high
9	Team and cohort diversity	High
10	Eligibility and compliance	Essential gate

Specialties

Dermatology

Eligibility Requirements

The principal investigator must be personally and actively responsible for the conduct of the proposed research, and eligible to apply for research grants under the guidelines of the applicant’s host institution. Only investigators working in the United States are eligible to apply. Early-stage investigators will be given priority. The HSF does not fund projects that are part of the NIH intramural research program, nor offers awards to private foundations without an academic affiliation to dermatology.

Sponsor Details

Sponsor Institute/Organizations: Hidradenitis Suppurativa Foundation

Sponsor Type: Corporate/Non-Profit

Address: 964 High House Road, #3064, Cary, NC 27513

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity